Your session is about to expire
← Back to Search
Cell Therapy
Intervention Group for Osteoarthritis (KICK-OA Trial)
N/A
Waitlist Available
Led By Daniel K White, PT, ScD, MSc
Research Sponsored by University of Delaware
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change in pain of target knee from baseline to 3 weeks, and change in pain of target knee from baseline to 3 months.
Awards & highlights
KICK-OA Trial Summary
This trial is testing whether an injection of autologous, nucleated cells can help improve symptoms for people with knee osteoarthritis.
Eligible Conditions
- Osteoarthritis of the Knee
KICK-OA Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change in pain of target knee from baseline to 3 weeks, and change in pain of target knee from baseline to 3 months.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change in pain of target knee from baseline to 3 weeks, and change in pain of target knee from baseline to 3 months.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Physical Activity
Secondary outcome measures
Function of Target Knee
Pain of Target Knee
KICK-OA Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Intervention GroupExperimental Treatment1 Intervention
Injection of Bone Marrow Concentrate (BMC)
Group II: Control GroupPlacebo Group1 Intervention
Injection of saline
Find a Location
Who is running the clinical trial?
University of DelawareLead Sponsor
155 Previous Clinical Trials
25,569 Total Patients Enrolled
6 Trials studying Osteoarthritis
438 Patients Enrolled for Osteoarthritis
Daniel K White, PT, ScD, MScPrincipal InvestigatorUniversity of Delaware
2 Previous Clinical Trials
168 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger